1. Home
  2. FPI vs CGEM Comparison

FPI vs CGEM Comparison

Compare FPI & CGEM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FPI
  • CGEM
  • Stock Information
  • Founded
  • FPI 2013
  • CGEM 2016
  • Country
  • FPI United States
  • CGEM United States
  • Employees
  • FPI N/A
  • CGEM N/A
  • Industry
  • FPI Real Estate Investment Trusts
  • CGEM Biotechnology: Pharmaceutical Preparations
  • Sector
  • FPI Real Estate
  • CGEM Health Care
  • Exchange
  • FPI Nasdaq
  • CGEM Nasdaq
  • Market Cap
  • FPI 607.9M
  • CGEM 506.1M
  • IPO Year
  • FPI 2014
  • CGEM 2021
  • Fundamental
  • Price
  • FPI $11.19
  • CGEM $7.53
  • Analyst Decision
  • FPI
  • CGEM Strong Buy
  • Analyst Count
  • FPI 0
  • CGEM 8
  • Target Price
  • FPI N/A
  • CGEM $32.86
  • AVG Volume (30 Days)
  • FPI 407.5K
  • CGEM 416.8K
  • Earning Date
  • FPI 04-29-2025
  • CGEM 05-14-2025
  • Dividend Yield
  • FPI 2.15%
  • CGEM N/A
  • EPS Growth
  • FPI 101.08
  • CGEM N/A
  • EPS
  • FPI 1.06
  • CGEM N/A
  • Revenue
  • FPI $58,351,000.00
  • CGEM N/A
  • Revenue This Year
  • FPI N/A
  • CGEM N/A
  • Revenue Next Year
  • FPI $2.82
  • CGEM $278.37
  • P/E Ratio
  • FPI $10.53
  • CGEM N/A
  • Revenue Growth
  • FPI 1.54
  • CGEM N/A
  • 52 Week Low
  • FPI $9.70
  • CGEM $7.90
  • 52 Week High
  • FPI $12.87
  • CGEM $30.19
  • Technical
  • Relative Strength Index (RSI)
  • FPI 48.33
  • CGEM 30.05
  • Support Level
  • FPI $10.94
  • CGEM $8.01
  • Resistance Level
  • FPI $11.19
  • CGEM $9.16
  • Average True Range (ATR)
  • FPI 0.19
  • CGEM 0.46
  • MACD
  • FPI 0.05
  • CGEM -0.05
  • Stochastic Oscillator
  • FPI 94.64
  • CGEM 0.50

About FPI Farmland Partners Inc.

Farmland Partners Inc owns and seeks to acquire high-quality farmland throughout North America. The company is an internally managed real estate company which owns and contracts farmland and storage facilities located across the United States. Majority of the properties in its portfolio are used to grow primary crops, such as corn, soybeans, wheat, rice and cotton, and rest to produce specialty crops, such as almonds, citrus, blueberries, and vegetables. The company generates its revenues through the rent it receives from its tenants.

About CGEM Cullinan Oncology Inc.

Cullinan Therapeutics Inc is a biopharmaceutical company. It has a diversified portfolio of clinical-stage assets that inhibit key drivers of disease or harness the immune system to eliminate diseased cells in both oncology and autoimmune diseases. Its understanding of oncology, immunology, and translational medicine, creates differentiated ideas, identifies the appropriate targets, and selects the optimal modality to develop transformative therapeutics across a variety of cancer and autoimmune indications. It has one reporting and one operating segment, which is the business of developing immunology and oncology therapies.

Share on Social Networks: